ID: ALA2146591

Max Phase: Preclinical

Molecular Formula: C19H14N2O3

Molecular Weight: 318.33

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COC(=O)c1ccc(-c2cc(-c3ccc4[nH]ccc4c3)on2)cc1

Standard InChI:  InChI=1S/C19H14N2O3/c1-23-19(22)13-4-2-12(3-5-13)17-11-18(24-21-17)15-6-7-16-14(10-15)8-9-20-16/h2-11,20H,1H3

Standard InChI Key:  DVRONTJOXSIWJQ-UHFFFAOYSA-N

Associated Targets(Human)

Calu-3 339 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 318.33Molecular Weight (Monoisotopic): 318.1004AlogP: 4.28#Rotatable Bonds: 3
Polar Surface Area: 68.12Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 0.17CX LogP: 4.04CX LogD: 4.04
Aromatic Rings: 4Heavy Atoms: 24QED Weighted: 0.57Np Likeness Score: -0.96

References

1. Md Tohid SF, Ziedan NI, Stefanelli F, Fogli S, Westwell AD..  (2012)  Synthesis and evaluation of indole-containing 3,5-diarylisoxazoles as potential pro-apoptotic antitumour agents.,  56  [PMID:22955095] [10.1016/j.ejmech.2012.08.009]

Source